Methods for Producing Insulin-Secreting Beta Cells From Human Pluripotent Stem Cells
First Claim
1. A method of culturing human pluripotent stem cells to produce posterior foregut cells, comprising the steps of:
- (a) culturing human pluripotent stem cells for about 3 days in the presence of a chemically defined medium under conditions that induce formation of mesendoderm/primitive streak and definitive endoderm cells, wherein the medium comprises an effective amount of;
i) fibroblast growth factor (FGF),ii) Activin A, andiii) bone morphogenetic protein (BMP);
(b) culturing the cells from step (a) for about 3 days in the presence of a chemically defined medium comprising an effective amount of;
i) insulin, transferrin, and selenium (ITS), andii) fibroblast growth factor (FGF);
and(c) culturing the cells from step (b) for about 4 days in the presence of a chemically defined medium comprising an effective amount of;
i) insulin, transferrin, and selenium (ITS), andii) Noggin-Nicotinamide-Retinoic acid (NNR),wherein the posterior foregut cells are produced.
4 Assignments
0 Petitions
Accused Products
Abstract
A method of culturing human pluripotent stem cells to produce pancreatic lineage, the method comprising the steps of (a) culturing the stem cells in the presence of a chemically defined medium comprising an effective amount of FGF, Activin A, and BMP; (b) culturing the cells from step (a) in the presence of a chemically defined medium comprising an effective amount of insulin, transferrin, and selenium (ITS), and FGF; (c) culturing the cells from step (b) in the presence of a chemically defined medium comprising an effective amount of insulin, transferrin, and selenium (ITS), and Noggin-Nicotinamide-Retinoic acid; and (d) culturing the cells from step (c) in the presence of a serum free chemically defined medium (ITSFINE and Noggin) comprising an effective amount of ITS, FGF7, islet neogenesis associated peptide (INGAP), nicotinamide, and Exendin-4, wherein pancreatic lineage cells are produced, wherein the pancreatic lineage cells are insulin+ cells.
-
Citations
22 Claims
-
1. A method of culturing human pluripotent stem cells to produce posterior foregut cells, comprising the steps of:
-
(a) culturing human pluripotent stem cells for about 3 days in the presence of a chemically defined medium under conditions that induce formation of mesendoderm/primitive streak and definitive endoderm cells, wherein the medium comprises an effective amount of; i) fibroblast growth factor (FGF), ii) Activin A, and iii) bone morphogenetic protein (BMP); (b) culturing the cells from step (a) for about 3 days in the presence of a chemically defined medium comprising an effective amount of; i) insulin, transferrin, and selenium (ITS), and ii) fibroblast growth factor (FGF); and (c) culturing the cells from step (b) for about 4 days in the presence of a chemically defined medium comprising an effective amount of; i) insulin, transferrin, and selenium (ITS), and ii) Noggin-Nicotinamide-Retinoic acid (NNR), wherein the posterior foregut cells are produced.
-
-
2. A method of culturing posterior foregut endoderm cells to produce cells of the pancreatic lineage, the method comprising the step of:
-
(a) culturing the posterior foregut endoderm cells for about 7 days in the presence of a serum free chemically defined medium (ITSFINE) comprising an effective amount of; i) insulin, transferrin, selenium, FGF7, islet neogenesis associated peptide (INGAP), nicotinamide, and exendin-4, and ii) Noggin, wherein pancreatic lineage cells are produced, wherein the pancreatic lineage cells are insulin+ cells.
-
-
3. A method of culturing human pluripotent stem cells to produce cells of the pancreatic lineage, the method comprising the steps of:
-
(a) culturing human pluripotent stem cells for about 3 days in the presence of a chemically defined medium under conditions that induce formation of mesendoderm/primitive streak and definitive endoderm cells, wherein the medium comprises an effective amount of; i) fibroblast growth factor (FGF), ii) Activin A, and iii) bone morphogenetic protein (BMP); (b) culturing the cells from step (a) for about 3 days in the presence of a chemically defined medium comprising an effective amount of; i) insulin, transferrin, and selenium (ITS), and ii) fibroblast growth factor (FGF); (c) culturing the cells from step (b) for about 4 days in the presence of a chemically defined medium under conditions that induce formation of posterior foregut cells, wherein the medium comprises an effective amount of; i) insulin, transferrin, and selenium (ITS), and ii) Noggin-Nicotinamide-Retinoic acid (NNR); and (d) culturing the cells from step (c) for about 7 days in the presence of a serum free chemically defined medium (ITSFINE) comprising an effective amount of; i) insulin, transferrin, selenium, FGF7, islet neogenesis associated peptide (INGAP), nicotinamide, and exendin-4, and ii) Noggin, wherein pancreatic lineage cells are produced, wherein the pancreatic lineage cells are insulin+ cells. - View Dependent Claims (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
-
-
20. A cell population comprising posterior foregut cells, the cell population is prepared by a method comprising the steps of:
-
(a) culturing human pluripotent stem cells for about 3 days in the presence of a chemically defined medium under conditions that induce formation of mesendoderm/primitive streak and definitive endoderm cells, wherein the medium comprises an effective amount of; i) fibroblast growth factor (FGF), ii) Activin A, and iii) bone morphogenetic protein (BMP); (b) culturing the cells from step (a) for about 3 days in the presence of a chemically defined medium comprising an effective amount of; i) insulin, transferrin, and selenium (ITS), and ii) fibroblast growth factor (FGF); and (c) culturing the cells from step (b) for about 4 days in the presence of a chemically defined medium comprising an effective amount of; i) insulin, transferrin, and selenium (ITS), and ii) Noggin-Nicotinamide-Retinoic acid (NNR), wherein the posterior foregut cells are produced.
-
-
21. A cell population comprising pancreatic lineage cells, the cell population is prepared by a method comprising the step of:
-
(a) culturing posterior foregut endoderm cells for about 7 days in the presence of a serum free chemically defined medium (ITSFINE) comprising an effective amount of; i) insulin, transferrin, selenium, FGF7, islet neogenesis associated peptide (INGAP), nicotinamide, and exendin-4, and ii) Noggin, wherein pancreatic lineage cells are produced, wherein the pancreatic lineage cells are insulin+ cells.
-
-
22. A cell population comprising pancreatic lineage cells, the cell population is prepared by a method comprising the steps of:
-
(a) culturing human pluripotent stem cells for about 3 days in the presence of a chemically defined medium under conditions that induce formation of mesendoderm/primitive streak and definitive endoderm cells, wherein the medium comprises an effective amount of; i) fibroblast growth factor (FGF), ii) Activin A, and iii) bone morphogenetic protein (BMP); (b) culturing the cells from step (a) for about 3 days in the presence of a chemically defined medium comprising an effective amount of; i) insulin, transferrin, and selenium (ITS), and ii) fibroblast growth factor (FGF); (c) culturing the cells from step (b) for about 4 days in the presence of a chemically defined medium under conditions that induce formation of posterior foregut cells, wherein the medium comprises an effective amount of; i) insulin, transferrin, and selenium (ITS), and ii) Noggin-Nicotinamide-Retinoic acid (NNR); and (d) culturing the cells from step (c) for about 7 days in the presence of a serum free chemically defined medium (ITSFINE) comprising an effective amount of; i) insulin, transferrin, selenium, FGF7, islet neogenesis associated peptide (INGAP), nicotinamide, and exendin-4, and ii) Noggin, wherein pancreatic lineage cells are produced, wherein the pancreatic lineage cells are insulin+ cells.
-
Specification